Teva Pharmaceutical Industries (TEVA) Liabilities from Discontinued Operations (2017)
Teva Pharmaceutical Industries (TEVA) posted quarterly Liabilities from Discontinued Operations of 38000000.0 for Q4 2017.
Teva Pharmaceutical Industries (TEVA) Liabilities from Discontinued Operations (2017) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has reported Liabilities from Discontinued Operations for 1 consecutive years, with 38000000.0 the latest figure, recorded in Q4 2017.
- Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 38000000.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was 38000000.0 (changed N/A YoY) and the FY2017 annual result came in at 38000000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations steadied at 38000000.0 in Q4 2017 per TEVA's latest filing.
- Over the last five years, Liabilities from Discontinued Operations for TEVA reached as high as 38000000.0 in Q4 2017 and fell as low as 38000000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 38.00 Mn |
| Dec 31, 2017 | 38.00 Mn |